| Product Code: ETC7550859 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Pharmacogenetic Testing Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 India Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 India Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 India Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 India Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 India Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 India Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 India Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 India Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness among healthcare professionals and patients about personalized medicine |
4.2.2 Growing demand for more effective and safer treatment options in healthcare |
4.2.3 Government initiatives to promote precision medicine and genetic testing |
4.3 Market Restraints |
4.3.1 High cost associated with pharmacogenetic testing |
4.3.2 Limited availability of skilled healthcare professionals proficient in interpreting genetic testing results |
4.3.3 Regulatory challenges and uncertainties related to genetic data privacy and data protection |
5 India Pharmacogenetic Testing Market Trends |
6 India Pharmacogenetic Testing Market, By Types |
6.1 India Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 India Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 India Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 India Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 India Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 India Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 India Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 India Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 India Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 India Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 India Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 India Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 India Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 India Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 India Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 India Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 India Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 India Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 India Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 India Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 India Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 India Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 India Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 India Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 India Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 India Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 India Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 India Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 India Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 India Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 India Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 India Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 India Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 India Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 India Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 India Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 India Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 India Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 India Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 India Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 India Pharmacogenetic Testing Market Export to Major Countries |
7.2 India Pharmacogenetic Testing Market Imports from Major Countries |
8 India Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare institutions offering pharmacogenetic testing services |
8.2 Adoption rate of pharmacogenetic testing in clinical practice |
8.3 Number of research studies and publications on pharmacogenetic testing in India |
9 India Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 India Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 India Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 India Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 India Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 India Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 India Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Pharmacogenetic Testing Market - Competitive Landscape |
10.1 India Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 India Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here